Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122336932 | 12233693 | 2 | F | 20160118 | 20160711 | 20160404 | 20160725 | EXP | DE-LUPIN PHARMACEUTICALS INC.-E2B_00005184 | LUPIN | 53.00 | YR | M | Y | 100.00000 | KG | 20160725 | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122336932 | 12233693 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | Y | UNKNOWN | 78103 | 40 | MG | |||||||
| 122336932 | 12233693 | 2 | C | Bisohexal | BISOPROLOL FUMARATE | 1 | Unknown | 0 | QD | ||||||||||
| 122336932 | 12233693 | 3 | C | Codiovan 160/12.5 mg | 2 | Unknown | 1X1/2 | 0 | |||||||||||
| 122336932 | 12233693 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 0 | 300 | MG | QD | ||||||||
| 122336932 | 12233693 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | Y | 0 | 500 | MG | BID | |||||||
| 122336932 | 12233693 | 6 | C | Sitagliptin | SITAGLIPTIN | 1 | Unknown | 0 | 100 | MG | QD | ||||||||
| 122336932 | 12233693 | 7 | C | Doxepin | DOXEPIN | 1 | Unknown | 0 | 25 | MG | QD | ||||||||
| 122336932 | 12233693 | 8 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 0 | |||||||||||
| 122336932 | 12233693 | 9 | C | Liprolog | INSULIN LISPRO | 1 | Subcutaneous | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122336932 | 12233693 | 1 | Hyperlipidaemia |
| 122336932 | 12233693 | 2 | Hypertension |
| 122336932 | 12233693 | 3 | Hypertension |
| 122336932 | 12233693 | 4 | Hyperuricaemia |
| 122336932 | 12233693 | 5 | Type 2 diabetes mellitus |
| 122336932 | 12233693 | 6 | Type 2 diabetes mellitus |
| 122336932 | 12233693 | 7 | Depression |
| 122336932 | 12233693 | 8 | Type 2 diabetes mellitus |
| 122336932 | 12233693 | 9 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122336932 | 12233693 | HO |
| 122336932 | 12233693 | OT |
| 122336932 | 12233693 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122336932 | 12233693 | Acute kidney injury | |
| 122336932 | 12233693 | Dialysis | |
| 122336932 | 12233693 | Pneumonia | |
| 122336932 | 12233693 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |